UK-Based Panel of Leading Experts Publish Their Review of the Latest Research and
Call for the Immediate Global Adoption of Ivermectin to Prevent and Treat COVID-19
WASHINGTON, D.C. – The Front Line COVID-19 Critical Care Alliance (FLCCC), a group of highly
published, world-renowned critical care physicians and scholars, heralded a new call from the
British Ivermectin Recommendation Development (BIRD) meeting that recommended the
immediate adoption of Ivermectin for the prevention and treatment of COVID-19. A link to
the proceedings document can be found on www.e-bmc.co.uk.
Convened by The Evidence-Based Medical Consultancy (E-BMC) in Bath, United Kingdom, the
BIRD meeting was assembled according to the World Health Organization Handbook of
Guideline Development to review the latest science on the safety and efficacy of Ivermectin
for the treatment and prevention of COVID-19. The expert panel included medical and
scientific experts from 16 countries, including Argentina, Australia, Belgium, Botswana,
Canada, France, Hungary, India, Ireland, Japan, Peru, Nigeria, South Africa, The Philippines,
United States, United Kingdom. Public and patient representatives were also present.
“This group is the latest in the growing number of experts from around the world who
recognize Ivermectin’s role in fighting this pandemic,” said Dr. Pierre Kory, president and chief
medical officer of the FLCCC. “The BIRD panel used the highest form of medical evidence, a
meta-analysis, to evaluate data from over 20 trials of Ivermectin before concluding it’s safe
and effective for use in treating COVID-19.”
“Compelling evidence exists as shown by this review, and clinicians in many countries are
using Ivermectin and have reported on the positive results they have observed,” said Dr. Tess
Lawrie, director of the Evidence-Based Medicine Consultancy. “It is troubling to think that
with every day that passes, the death toll of this pandemic grows when an effective treatment
was, all along, right under our noses.”
The E-BMC shared the BIRD proceedings document and recommendation with officials at the
World Health Organization, the U.S. National Institutes of Health, and the U.S. Food and Drug
Administration.
